ACE2 and COVID-19: It is known that SARS-CoV-2 enters the host cells through the membrane-bound ACE2 exopeptidase, and hypomethylation of ACE2 may potentially increase its expression, thereby elevating the risk of infection [29] and accordingly elevating the risk of post-COVID-19 condition.